Secondary Logo

Journal Logo

Committee Opinion No. 738: Aromatase Inhibitors in Gynecologic Practice: Correction

doi: 10.1097/AOG.0000000000002879
Departments: Correction
Free

In “Committee Opinion No. 738: Aromatase Inhibitors in Gynecologic Practice” from the American College of Obstetricians and Gynecologists,1 there is an error on page e196, second column, first paragraph. In the first full sentence, the phrase “letrozole was more effective than clomiphene citrate with a higher live birth rate (27.5% versus 10.1%. P=.007)” is incorrect and should instead read, “letrozole was more effective than clomiphene citrate with a higher live birth rate (27.5% versus 19.1%, P=.007).” The full, corrected sentence is as follows: “However, in a more recent randomized controlled trial, letrozole was more effective than clomiphene citrate with a higher live birth rate (27.5% versus 19.1%, P=.007), and cumulative ovulation rate (61.7% versus 48.3%, P<.001) (29).”

Back to Top | Article Outline

Reference

Aromatase inhibitors in gynecologic practice. ACOG Committee Opinion No. 738. American College of Obstetricians and Gynecologists. Obstet Gynecol 2018;131:e194–9.
    © 2018 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.